Accelerating measles and rubella elimination through research and innovation – Findings from the Measles & Rubella Initiative research prioritization process, 2016

Gavin B. Grant, Balcha G. Masresha, William J Moss, Mick N. Mulders, Paul A. Rota, Saad B. Omer, Abigail Shefer, Jennifer L. Kriss, Matt Hanson, David N. Durrheim, Robert Linkins, James L. Goodson

Research output: Contribution to journalArticle

Abstract

The Measles & Rubella Initiative (M&RI) identified five key strategies to achieve measles and rubella elimination, including research and innovation to support cost-effective operations and improve vaccination and diagnostic tools. In 2016, the M&RI Research and Innovation Working Group (R&IWG) completed a research prioritization process to identify key research questions and update the global research agenda. The R&IWG reviewed meeting reports and strategic planning documents and solicited programmatic inputs from vaccination experts at the program operational level through a web survey, to identify previous research priorities and new research questions. The R&IWG then convened a meeting of experts to prioritize the identified research questions in four strategic areas: (1) epidemiology and economics, (2) surveillance and laboratory, (3) immunization strategies, and (4) demand creation and communications. The experts identified 19 priority research questions in the four strategic areas to address key areas of work necessary to further progress toward elimination. Future commitments from partners will be needed to develop a platform for improved coordination with adequate and predictable resources for research implementation and innovation to address these identified priorities.

Original languageEnglish (US)
JournalVaccine
DOIs
StatePublished - Jan 1 2019

Fingerprint

prioritization
Rubella
Measles
Research
Vaccination
vaccination
communication (human)
epidemiology
Immunization
immunization
Epidemiology
planning
Economics
Costs and Cost Analysis
economics

Keywords

  • Eradication
  • Immunization
  • Measles
  • Research
  • Rubella
  • Vaccines

ASJC Scopus subject areas

  • Molecular Medicine
  • Immunology and Microbiology(all)
  • veterinary(all)
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

Accelerating measles and rubella elimination through research and innovation – Findings from the Measles & Rubella Initiative research prioritization process, 2016. / Grant, Gavin B.; Masresha, Balcha G.; Moss, William J; Mulders, Mick N.; Rota, Paul A.; Omer, Saad B.; Shefer, Abigail; Kriss, Jennifer L.; Hanson, Matt; Durrheim, David N.; Linkins, Robert; Goodson, James L.

In: Vaccine, 01.01.2019.

Research output: Contribution to journalArticle

Grant, Gavin B. ; Masresha, Balcha G. ; Moss, William J ; Mulders, Mick N. ; Rota, Paul A. ; Omer, Saad B. ; Shefer, Abigail ; Kriss, Jennifer L. ; Hanson, Matt ; Durrheim, David N. ; Linkins, Robert ; Goodson, James L. / Accelerating measles and rubella elimination through research and innovation – Findings from the Measles & Rubella Initiative research prioritization process, 2016. In: Vaccine. 2019.
@article{c0f1496f245f40f2a50d5a0e4a88fc69,
title = "Accelerating measles and rubella elimination through research and innovation – Findings from the Measles & Rubella Initiative research prioritization process, 2016",
abstract = "The Measles & Rubella Initiative (M&RI) identified five key strategies to achieve measles and rubella elimination, including research and innovation to support cost-effective operations and improve vaccination and diagnostic tools. In 2016, the M&RI Research and Innovation Working Group (R&IWG) completed a research prioritization process to identify key research questions and update the global research agenda. The R&IWG reviewed meeting reports and strategic planning documents and solicited programmatic inputs from vaccination experts at the program operational level through a web survey, to identify previous research priorities and new research questions. The R&IWG then convened a meeting of experts to prioritize the identified research questions in four strategic areas: (1) epidemiology and economics, (2) surveillance and laboratory, (3) immunization strategies, and (4) demand creation and communications. The experts identified 19 priority research questions in the four strategic areas to address key areas of work necessary to further progress toward elimination. Future commitments from partners will be needed to develop a platform for improved coordination with adequate and predictable resources for research implementation and innovation to address these identified priorities.",
keywords = "Eradication, Immunization, Measles, Research, Rubella, Vaccines",
author = "Grant, {Gavin B.} and Masresha, {Balcha G.} and Moss, {William J} and Mulders, {Mick N.} and Rota, {Paul A.} and Omer, {Saad B.} and Abigail Shefer and Kriss, {Jennifer L.} and Matt Hanson and Durrheim, {David N.} and Robert Linkins and Goodson, {James L.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.vaccine.2019.01.081",
language = "English (US)",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Accelerating measles and rubella elimination through research and innovation – Findings from the Measles & Rubella Initiative research prioritization process, 2016

AU - Grant, Gavin B.

AU - Masresha, Balcha G.

AU - Moss, William J

AU - Mulders, Mick N.

AU - Rota, Paul A.

AU - Omer, Saad B.

AU - Shefer, Abigail

AU - Kriss, Jennifer L.

AU - Hanson, Matt

AU - Durrheim, David N.

AU - Linkins, Robert

AU - Goodson, James L.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The Measles & Rubella Initiative (M&RI) identified five key strategies to achieve measles and rubella elimination, including research and innovation to support cost-effective operations and improve vaccination and diagnostic tools. In 2016, the M&RI Research and Innovation Working Group (R&IWG) completed a research prioritization process to identify key research questions and update the global research agenda. The R&IWG reviewed meeting reports and strategic planning documents and solicited programmatic inputs from vaccination experts at the program operational level through a web survey, to identify previous research priorities and new research questions. The R&IWG then convened a meeting of experts to prioritize the identified research questions in four strategic areas: (1) epidemiology and economics, (2) surveillance and laboratory, (3) immunization strategies, and (4) demand creation and communications. The experts identified 19 priority research questions in the four strategic areas to address key areas of work necessary to further progress toward elimination. Future commitments from partners will be needed to develop a platform for improved coordination with adequate and predictable resources for research implementation and innovation to address these identified priorities.

AB - The Measles & Rubella Initiative (M&RI) identified five key strategies to achieve measles and rubella elimination, including research and innovation to support cost-effective operations and improve vaccination and diagnostic tools. In 2016, the M&RI Research and Innovation Working Group (R&IWG) completed a research prioritization process to identify key research questions and update the global research agenda. The R&IWG reviewed meeting reports and strategic planning documents and solicited programmatic inputs from vaccination experts at the program operational level through a web survey, to identify previous research priorities and new research questions. The R&IWG then convened a meeting of experts to prioritize the identified research questions in four strategic areas: (1) epidemiology and economics, (2) surveillance and laboratory, (3) immunization strategies, and (4) demand creation and communications. The experts identified 19 priority research questions in the four strategic areas to address key areas of work necessary to further progress toward elimination. Future commitments from partners will be needed to develop a platform for improved coordination with adequate and predictable resources for research implementation and innovation to address these identified priorities.

KW - Eradication

KW - Immunization

KW - Measles

KW - Research

KW - Rubella

KW - Vaccines

UR - http://www.scopus.com/inward/record.url?scp=85063090996&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063090996&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2019.01.081

DO - 10.1016/j.vaccine.2019.01.081

M3 - Article

C2 - 30904317

AN - SCOPUS:85063090996

JO - Vaccine

JF - Vaccine

SN - 0264-410X

ER -